MAPK8 and cancer: The c-Jun NH2-terminal kinases (JNKs), a subgroup of mitogen-activated protein kinases, are often deregulated in a variety of human cancers including pancreatic cancer, although the role and significance of JNK deregulation in such human cancers have not been fully delineated [17-21].